Autism spectrum disorders (ASD) are characterized by impairment in social interactions, communication deficits, and restricted repetitive interests and behaviors. Recent evidence has suggested that impairments of innate immunity may play an important role in ASD. To test this hypothesis, we isolated peripheral blood monocytes from 17 children with ASD and 16 age-matched typically developing (TD) controls and stimulated these cell cultures in vitro with distinct toll-like receptors (TLR) ligands: TLR 2 (lipoteichoic acid; LTA), TLR 3 (poly I:C), TLR 4 (lipopolysaccharide; LPS), TLR 5 (flagellin), and TLR 9 (CpG-B). Supernatants were harvested from the cell cultures and pro-inflammatory cytokine responses for IL-1b, IL-6, IL-8, TNFa, MCP-1, and GM-CSF were determined by multiplex Luminex analysis. After in vitro challenge with TLR ligands, differential cytokine responses were observed in monocyte cultures from children with ASD compared with TD control children. In particular, there was a marked increase in pro-inflammatory IL-1b, IL-6, and TNFa responses following TLR 2, and IL-1b response following TLR 4 stimulation in monocyte cultures from children with ASD (p < 0.04). Conversely, following TLR 9 stimulation there was a decrease in IL-1b, IL-6, GM-CSF, and TNFa responses in monocyte cell cultures from children with ASD compared with controls (p < 0.05). These data indicate that, monocyte cultures from children with ASD are more responsive to signaling via select TLRs. As monocytes are key regulators of the immune response, dysfunction in the response of these cells could result in long-term immune alterations in children with ASD that may lead to the development of adverse neuroimmune interactions and could play a role in the pathophysiology observed in ASD.
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Introduction
Autism spectrum disorders (ASD) are complex neurodevelopmental disorders appearing in the first few years of life and are characterized by deficits in communication and social interaction, as well as specific stereotypical behaviors. ASD develops in approximately 1.3 per 1000 children, with a disproportionate (4:1) number of males affected (Fombonne, 2005) . At present, the etiology of ASD for the majority of cases is not known and is most likely a combination of genetic and environmental factors. Dysregulated immune function is a recurrent finding in ASD, including evidence of brain reactive antibodies; skewed T cell responses to mitogens; altered cytokine levels in the brain, CSF, and periphery; and altered function of innate immune cells such as monocytes and NK cells (Ashwood et al., 2009; Ashwood and Wakefield, 2006; Cabanlit et al., 2007; Denney et al., 1996; Enstrom et al., 2009b; Garbett et al., 2008; Gupta et al., 1998; Li et al., 2009; Molloy et al., 2006; Sweeten et al., 2003; Vargas et al., 2005; Wills et al., 2007) . In addition, several potential genetic mechanisms that impact immune function and responses have been implicated, such as complement C4B null allele (Odell et al., 2005; Samano et al., 2004) , MET (Campbell et al., 2007) , MIF (Grigorenko et al., 2008) reelin (Persico et al., 2001; Skaar et al., 2005) , and certain human leukocyte allele (HLA) haplotypes (Torres et al., 2001; Warren et al., 1996) . However, any underlying immune mechanism resulting in dysregulation has not to date been elucidated.
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